Percutaneous left ventricular assist device in high risk percutaneous coronary intervention

• DOI: 10.21037/jtd.2016.01.77
• Publication Date: 2016-03-18T08:35:03Z
• Authors: Omar Kahaly; Konstantinos Dean...
• Keywords: Impella

High-risk candidates for percutaneous coronary intervention (PCI) may include patients with severe multi-vessel artery disease, unprotected left main stenosis, or last patent conduit a especially in ventricular (LV) ejection fraction of ≤35% (1-4). In addition, the condition and co-morbidities patient should be taken into consideration. Traditionally, revascularization these could better accomplished bypass graft (CABG) surgery; however, sometimes are high-risk surgical candidates, have advanced age and/or poor distal targets surgery (5). PCI is viable option, episodic interruption blood flow to target during contrast dye injections, balloon inflation stent implantation result decrease LV performance raising procedural morbidity mortality (3,4,6). Currently, it thought that hemodynamic support devices like Impella (Abiomed, Danvers, Massachusetts) assist device (PLVAD) intra-aortic pump (IABP) provide (2,3,7-9).